Back
Equity Residential 10K Form
Sell
34
EQR
Equity Residential
Last Price:
$72.29
Seasonality Move:
0.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | EQR/Equity Residential Quarterly |
2024-02-15 | 10K | EQR/Equity Residential Annual |
2023-11-02 | 10Q | EQR/Equity Residential Quarterly |
2023-08-02 | 10Q | EQR/Equity Residential Quarterly |
2023-04-28 | 10Q | EQR/Equity Residential Quarterly |
2023-02-16 | 10K | EQR/Equity Residential Annual |
Receive EQR News And Ratings
See the #1 stock for the next 7 days that we like better than EQR
EQR Financial Statistics
Sales & Book Value
Annual Sales: | $2.9B |
---|---|
Cash Flow: | $320.2M |
Price / Cash Flow: | 22.71 |
Annual Sales: | $28.57 |
Price / Book: | 2.5 |
Profitability
EPS (TTM): | 2.44000 |
---|---|
Net Income (TTM): | $928.4M |
Gross Margin: | $1.8B |
Return on Equity: | 8.06% |
Return on Assets: | 4.61% |
Equity Residential Earnings Forecast
Key Equity Residential Financial Ratios
-
The Gross Profit Margin over the past 17 years for EQR is 63.59%.
-
The Selling, General & Administrative Expenses for EQR have been equal to 2.11% of Gross Profit Margin.
-
The Interest Expense is 32.27% of Operating Income.
-
The Net Earning history of EQR is 29.07% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 17 years.
Equity Residential Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Residential REITs |
Sector: | Real Estate |
Current Symbol: | EQR |
CUSIP: | 29476L |
Website: | equityapartments.com |
Debt
Debt-to-Equity Ratio: | 0.77 |
---|---|
Current Ratio: | 0.1 |
Quick Ratio: | 0.02 |
Price-to-Earnings
Trailing P/E Ratio: | 32.47 |
---|---|
Forward P/E Ratio: | 44.5 |
EQR Technical Analysis vs Fundamental Analysis
Sell
34
Equity Residential (EQR)
is a Sell
Is Equity Residential a Buy or a Sell?
-
Equity Residential stock is rated a SellThe current Equity Residential [EQR] share price is $71.44. The Score for EQR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.